X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
Debt to Equity Over TimeCompressed
Percentile Rank50
3Y CAGR-7.2%
5Y CAGR-4.7%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
-7.2%/yr
vs +9.2%/yr prior
5Y CAGR
-4.7%/yr
Consistent
Acceleration
-16.3pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.41 | -88.2% |
| 2024 | 3.53 | +209.1% |
| 2023 | 1.14 | +119.8% |
| 2022 | 0.52 | -16.0% |
| 2021 | 0.62 | +17.0% |
| 2020 | 0.53 | +197.8% |
| 2019 | 0.18 | -51.5% |
| 2018 | 0.37 | +75.3% |
| 2017 | 0.21 | +177.1% |
| 2016 | -0.27 | - |